Cargando…

Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies

Hepatocellular carcinoma (HCC) is a significant cause of cancer-related mortality owing to resistance to traditional treatments and tumor recurrence after therapy, which leads to poor therapeutic outcomes. Cancer stem cells (CSC) are a small subset of tumor cells with the capability to influence sel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yu-Chin, Yeh, Chau-Ting, Lin, Kwang-Huei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349579/ https://www.ncbi.nlm.nih.gov/pubmed/32466488 http://dx.doi.org/10.3390/cells9061331

Ejemplares similares

Thyroid Hormone in Hepatocellular Carcinoma: Cancer Risk, Growth Regulation, and Anticancer Drug Resistance
por: Lin, Yang-Hsiang, et al.
Publicado: (2020)

Molecular Functions of Thyroid Hormone Signaling in Regulation of Cancer Progression and Anti-Apoptosis
por: Liu, Yu-Chin, et al.
Publicado: (2019)

Reply to Comments: “Molecular Functions of Thyroid Hormone Signaling in Regulation of Cancer Progression and Anti-Apoptosis” Int. J. Mol. Sci., 2019, 20, 4986
por: Liu, Yu-Chin, et al.
Publicado: (2020)

Correction: Lin, K.-H., et al. Molecular Functions of Thyroid Hormone Signaling in Regulation of Cancer Progression and Anti-Apoptosis. Int. J. Mol. Sci., 2019, 20, 4986
por: Liu, Yu-Chin, et al.
Publicado: (2020)

Radiosensitization of Hepatocellular Carcinoma through Targeting Radio-Associated MicroRNA
por: Wu, Cheng-Heng, et al.
Publicado: (2020)

Roles of Thyroid Hormone-Associated microRNAs Affecting Oxidative Stress in Human Hepatocellular Carcinoma
por: Huang, Po-Shuan, et al.
Publicado: (2019)

TUG1 Is a Regulator of AFP and Serves as Prognostic Marker in Non-Hepatitis B Non-Hepatitis C Hepatocellular Carcinoma †
por: Lin, Yang-Hsiang, et al.
Publicado: (2020)

Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategies
por: Wang, Nuozhou, et al.
Publicado: (2018)

LPAL2 Suppresses Tumor Growth and Metastasis of Hepatocellular Carcinoma by Modulating MMP9 Expression
por: Lin, Yang-Hsiang, et al.
Publicado: (2022)

Furin Overexpression Suppresses Tumor Growth and Predicts a Better Postoperative Disease-Free Survival in Hepatocellular Carcinoma
por: Huang, Ya-Hui, et al.
Publicado: (2012)

Roles of Long Noncoding RNAs in Recurrence and Metastasis of Radiotherapy-Resistant Cancer Stem Cells
por: Chi, Hsiang-Cheng, et al.
Publicado: (2017)

Is there a sex difference in postoperative prognosis of hepatocellular carcinoma?
por: Lai, Ming-Wei, et al.
Publicado: (2019)

Identification of Postoperative Prognostic MicroRNA Predictors in Hepatocellular Carcinoma
por: Huang, Ya-Hui, et al.
Publicado: (2012)

WWOX-rs13338697 genotype predicts therapeutic efficacy of ADI-PEG 20 for patients with advanced hepatocellular carcinoma
por: Chu, Yu-De, et al.
Publicado: (2022)

A Comprehensive Review on Cancer Vaccines and Vaccine Strategies in Hepatocellular Carcinoma
por: Tojjari, Alireza, et al.
Publicado: (2023)

Clinical Limitations of Tissue Annexin A2 Level as a Predictor of Postoperative Overall Survival in Patients with Hepatocellular Carcinoma
por: Huang, Shu-Wei, et al.
Publicado: (2021)

A Circulating MicroRNA Signature Capable of Assessing the Risk of Hepatocellular Carcinoma in Cirrhotic Patients
por: Huang, Ya-Hui, et al.
Publicado: (2017)

Inhibition of Bruton’s tyrosine kinase as a therapeutic strategy for chemoresistant oral squamous cell carcinoma and potential suppression of cancer stemness
por: Liu, Shao-Cheng, et al.
Publicado: (2021)

Long Non-Coding RNAs as Mediators of Tumor Microenvironment and Liver Cancer Cell Communication
por: Lin, Yang-Hsiang, et al.
Publicado: (2018)

A Single Nucleotide Polymorphism rs1010816 Predicts Sorafenib Therapeutic Outcomes in Advanced Hepatocellular Carcinoma
por: Lin, Chih-Lang, et al.
Publicado: (2023)

Trial Designs for Integrating Novel Therapeutics into the Management of Intermediate-Stage Hepatocellular Carcinoma
por: Su, Yung-Yeh, et al.
Publicado: (2022)

Melatonin Sensitizes Hepatocellular Carcinoma Cells to Chemotherapy Through Long Non-Coding RNA RAD51-AS1-Mediated Suppression of DNA Repair
por: Chen, Chin-Chuan, et al.
Publicado: (2018)

Molecular functions and clinical impact of thyroid hormone-triggered autophagy in liver-related diseases
por: Chi, Hsiang-Cheng, et al.
Publicado: (2019)

CRNDE acts as an epigenetic modulator of the p300/YY1 complex to promote HCC progression and therapeutic resistance
por: Liu, Yu-Chin, et al.
Publicado: (2022)

IFITM3 promotes malignant progression, cancer stemness and chemoresistance of gastric cancer by targeting MET/AKT/FOXO3/c-MYC axis
por: Chu, Pei-Yi, et al.
Publicado: (2022)

Therapeutic strategies for post-transplant recurrence of hepatocellular carcinoma
por: Sposito, Carlo, et al.
Publicado: (2022)

Lenvatinib applicability in the therapeutic strategy of patients with hepatocellular carcinoma
por: Merle, Philippe
Publicado: (2023)

A novel risk score for hepatocellular carcinoma in Asian cirrhotic patients: a multicentre prospective cohort study
por: Liang, Kung-Hao, et al.
Publicado: (2018)

New Therapeutic Options for Advanced Hepatocellular Carcinoma
por: Ma, Yu-Shui, et al.
Publicado: (2020)

Small Nucleolar RNAs and Their Comprehensive Biological Functions in Hepatocellular Carcinoma
por: Liu, Xiaoyu, et al.
Publicado: (2022)

Cyclin-dependent kinase-associated protein phosphatase is overexpressed in alcohol-related hepatocellular carcinoma and influences xenograft tumor growth
por: LIN, WEY-RAN, et al.
Publicado: (2012)

Early diagnosis and therapeutic strategies for hepatocellular carcinoma: From bench to bedside
por: Guan, Ming-Cheng, et al.
Publicado: (2021)

Hepatic Stellate Cell Modulates the Immune Microenvironment in the Progression of Hepatocellular Carcinoma
por: Wang, Pei-Wen, et al.
Publicado: (2022)

Therapeutic Strategies Against Cancer Stem Cells in Esophageal Carcinomas
por: Das, Plabon Kumar, et al.
Publicado: (2021)

Impact of an MT-RNR1 Gene Polymorphism on Hepatocellular Carcinoma Progression and Clinical Characteristics
por: Lin, Yang-Hsiang, et al.
Publicado: (2021)

Tenofovir Hampers the Efficacy of Sorafenib in Prolonging Overall Survival in Hepatocellular Carcinoma
por: Liang, Kung-Hao, et al.
Publicado: (2021)

GALNT14: An Emerging Marker Capable of Predicting Therapeutic Outcomes in Multiple Cancers
por: Lin, Wey-Ran, et al.
Publicado: (2020)

Comprehensive Analysis and Drug Modulation of Human Endogenous Retrovirus in Hepatocellular Carcinomas
por: Chang, Ya-Sian, et al.
Publicado: (2023)

Comprehensive analysis of the prognostic value and functions of prefoldins in hepatocellular carcinoma
por: Ke, Shanjia, et al.
Publicado: (2022)

Comprehensive analysis of transcriptome profiles in hepatocellular carcinoma
por: Jin, Yu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mphbqa45hr64mr0tbn2h1kdg14